Abingdon Health (ABDX) Competitors GBX 7.75 0.00 (0.00%) (As of 12/20/2024 10:41 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades ABDX vs. AGL, YGEN, GDR, PRM, GENI, VRCI, LLAI, IDHC, DMTR, and LLAShould you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), genedrive (GDR), Proteome Sciences (PRM), GENinCode (GENI), Verici Dx (VRCI), LungLife AI (LLAI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry. Abingdon Health vs. ANGLE Yourgene Health genedrive Proteome Sciences GENinCode Verici Dx LungLife AI Integrated Diagnostics Deepmatter Group LLA.L,0P0001T9GN,0 Abingdon Health (LON:ABDX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Do insiders & institutionals believe in ABDX or AGL? 33.5% of Abingdon Health shares are owned by institutional investors. Comparatively, 18.8% of ANGLE shares are owned by institutional investors. 48.9% of Abingdon Health shares are owned by insiders. Comparatively, 16.2% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, ABDX or AGL? Abingdon Health has a beta of 0.13, indicating that its share price is 87% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Which has preferable earnings & valuation, ABDX or AGL? Abingdon Health has higher revenue and earnings than ANGLE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbingdon Health£6.13M2.40-£1.27MN/AN/AANGLE£2.02M14.90-£18.03M-£0.07-133.33 Is ABDX or AGL more profitable? ANGLE has a net margin of 0.00% compared to Abingdon Health's net margin of -20.72%. Abingdon Health's return on equity of -48.69% beat ANGLE's return on equity.Company Net Margins Return on Equity Return on Assets Abingdon Health-20.72% -48.69% -17.93% ANGLE N/A -63.75%-29.89% Does the MarketBeat Community prefer ABDX or AGL? ANGLE received 182 more outperform votes than Abingdon Health when rated by MarketBeat users. CompanyUnderperformOutperformAbingdon HealthN/AN/AANGLEOutperform Votes18262.33% Underperform Votes11037.67% Does the media refer more to ABDX or AGL? In the previous week, Abingdon Health's average media sentiment score of 0.00 equaled ANGLE'saverage media sentiment score. Company Overall Sentiment Abingdon Health Neutral ANGLE Neutral Do analysts recommend ABDX or AGL? ANGLE has a consensus price target of GBX 70, suggesting a potential upside of 650.03%. Given ANGLE's stronger consensus rating and higher possible upside, analysts plainly believe ANGLE is more favorable than Abingdon Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abingdon Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ANGLE 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryANGLE beats Abingdon Health on 8 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get Abingdon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABDX vs. The Competition Export to ExcelMetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£14.69M£27.75M£5.14B£1.89BDividend YieldN/A5.44%5.09%5.46%P/E Ratio-899.002.0090.131,843.16Price / Sales2.402,398.621,117.09389,641.00Price / Cash2.2511.4243.1028.69Price / Book7.753.044.782.78Net Income-£1.27M£53.40M£120.31M£155.66M7 Day Performance3.33%-3.11%-1.92%-2.01%1 Month Performance6.24%0.23%13.65%21.46%1 Year Performance-15.67%-14.53%28.34%29.47% Abingdon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABDXAbingdon HealthN/AGBX 7.75flatN/A-10.6%£14.69M£6.13M-899.0084AGLANGLE1.1003 of 5 starsGBX 10.51-2.2%GBX 70+566.0%-17.0%£33.90M£2.02M-153.57650YGENYourgene HealthN/AGBX 0.52flatN/A+0.0%£16.43M£29.67M-51.50253GDRgenedriveN/AGBX 2.24-0.4%N/A-74.1%£12.17M£49,000.00-57.4843Insider TradeNews CoveragePRMProteome SciencesN/AGBX 2.68+1.1%N/A-38.3%£7.91M£4.04M-291.00240GENIGENinCodeN/AGBX 3.80-3.2%N/A-30.2%£6.72M£2.60M-78.522,300Gap UpVRCIVerici DxN/AGBX 2.63+1.9%N/A-73.5%£6.37M£4.33M-131.2519LLAILungLife AIN/AGBX 9.50flatN/A-81.1%£2.91M£98,566.00-69.2315High Trading VolumeIDHCIntegrated DiagnosticsN/AGBX 0.44-2.6%N/A+23.3%£2.58M£4.75B14.756,692Gap DownDMTRDeepmatter GroupN/AGBX 0.03+22.2%N/AN/A£1.33M£1.04M-0.11N/AGap DownLLALLA.L,0P0001T9GN,0N/AGBX 15flatN/AN/A£0.00N/A-125.0015High Trading Volume Related Companies and Tools Related Companies ANGLE Alternatives Yourgene Health Alternatives genedrive Alternatives Proteome Sciences Alternatives GENinCode Alternatives Verici Dx Alternatives LungLife AI Alternatives Integrated Diagnostics Alternatives Deepmatter Group Alternatives LLA.L,0P0001T9GN,0 Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:ABDX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abingdon Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abingdon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
